Engflag

Chlorhexidine C

Quick links to important sections

Chlorhexidine C

Selected form

There is no image.

Method of action: Antiseptics And Disinfectants, Disinfectant, Stomatological Preparations, Throat Preparations

Treatment option: Gingivitis, Infection, Candidiasis,Oral, Infant Thrush, AIDS / HIV, Stomatitis, Dental, Tuberculosis, Surgery

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Chlorhexidine C

Chlorhexidine C is an antimicrobial agent defined by its active ingredient, Chlorhexidine Gluconate (CHG). It functions as a powerful, broad-spectrum topical antiseptic and disinfectant designed for localized hygiene, targeting germs on body surfaces rather than being absorbed into the body for systemic effects.

Quick Facts

Property Description
Active ingredient Chlorhexidine Gluconate (CHG)
Pharmacological class Antiseptic and Disinfectant
Origin Synthetic (Cationic Bis-guanide)
Route of administration Topical or Oral
Common forms Solution, Oral Rinse, Gel, Cream

Identity, Composition, and Classification

The primary component is Chlorhexidine Gluconate, which is classified chemically as a cationic bis-guanide, confirming its synthetic origin. This compound has been extensively studied in pharmaceutical literature and is clinically recognized for its efficacy in infection control.

The active ingredient is formulated into several identity-level dosage forms, including solutions (often alcoholic or aqueous bases), specific Oral Rinses for mucosal use, and Topical Creams or Gels. These forms facilitate its primary application via the topical or oral routes, such as its use in pre-operative skin preparation or during routine oral hygiene.

General Purpose and Mechanism Summary

The general purpose of Chlorhexidine C is to provide effective, localized germ control, supporting hygiene by rapidly and significantly reducing the concentration of microbes. The mechanism is based on the compound's positive charge, which causes it to bind strongly to the negatively charged cell walls of microorganisms. This physical bond damages the cell membrane, which quickly leads to the neutralization and elimination of the pathogen. This mechanism of rapid pathogen disruption is the essential foundation for its use as a reliable agent for local sanitation.

What side effects are possible with Chlorhexidine C?

Possible side effects and safety information

The safety profile for Chlorhexidine C is primarily characterized by localized effects at the site of administration, alongside a documented, though rare, risk of systemic reactions. These classifications are based strictly on official regulatory documents, such as those from the FDA and EMA.

Adverse Reactions by Frequency and System

Adverse reactions are grouped by the system-organ class involved and their regulatory frequency:

  • Common Reactions (Gastrointestinal, Procedural): The oral rinse formulation frequently reports staining of the teeth, tongue, or dental restorations, as well as an increase in supragingival calculus formation. Taste alteration (dysgeusia) and a feeling of dry mouth (xerostomia) are also categorized as common with oral use.

  • Local and Systemic Reactions (Skin, Immune System): Local irritation or burning sensations are documented. Of particular regulatory note, anaphylaxis and severe generalized hypersensitivity reactions are described as serious adverse reactions, categorized under Immune system disorders, despite being rare or of unknown frequency.

Safety Patterns and Constraints

The official labeling notes specific safety patterns related to exposure. Staining and increased calculus formation are associated with the long-term use of the oral preparation. Conversely, taste alteration is often described as a transient effect.

A central safety restriction is the absolute contraindication for any individual with a documented history of hypersensitivity or allergic reaction to Chlorhexidine Gluconate or any other component in the formulation. This constraint establishes the fundamental safety limit for the medicine.

This structure ensures the risks are communicated neutrally, separating the expected, common local consequences from the critical, rare systemic immune risks as documented by regulatory authorities.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — official regulatory information for Chlorhexidine C

Overdose Scope

The profile identifies two primary scenarios. Documented overdose presentations following accidental ingestion, particularly of oral rinse formulations, include gastric distress, nausea, or signs of alcohol intoxication such as slurred speech or a staggering walk. The Physiological systems affected by severe allergic reactions include the Cardiovascular system (hypotension, circulatory collapse) and Respiratory system (wheezing, difficulty breathing), which can progress to shock. Dose-related factors for urgent action involve ingestion of more than 4 ounces of the oral rinse by a small child. Population-specific overdose notes caution that premature infants are at risk of chemical burns from topical solutions.

Overdose Classifications (High-Level)

The Severity classification is documented to include life-threatening events like anaphylaxis and fatal outcomes, based on Regulatory basis from the FDA and EMA. Overdose-context constraints confirm that management relies on symptomatic and supportive measures, as no specific antidote is known.

Resulting Overdose Structure

Official overdose statements:

  • The onset of wheezing, facial swelling, or severe rash is the trigger for patients to seek medical attention immediately.
  • If a child shows signs of intoxication after ingestion, a Poison Control Center must be contacted right away, with gastric lavage described as an advisable procedure.
  • Accidental exposure to the eye necessitates immediate and thorough rinsing with water to prevent irreversible corneal damage.

Connection to the overall overdose profile

Regulatory documents define the official overdose profile based on two acute risks: the immediate, life-threatening systemic hypersensitivity and the specific hazards of accidental ingestion or severe local exposure. These statements mandate that the onset of symptoms like hypotension or slurred speech serves as the explicit trigger for patients to seek immediate emergency medical help.

Therapeutic Uses of Chlorhexidine C

What Chlorhexidine C Treats: Main Uses and Benefits

Chlorhexidine C is commonly used in therapeutic domains where localized discomfort and the management of certain symptomatic manifestations are needed. It is considered relevant for conditions characterized by periods of heightened symptoms in both the oral cavity and on the skin.

The product is commonly used to help with symptomatic manifestations of gingivitis (swollen, red, or bleeding gums) and is applied in contexts requiring supportive care for minor surface wounds (cuts, scrapes, and abrasions). Regarding the prescription oral rinse, it is used for easing symptoms such as redness, swelling, and bleeding associated with gum inflammation.

The medication contributes to easing the overall symptom load during periods of heightened symptoms. The product may assist with maintaining functional stability and coping more steadily with difficult symptomatic episodes characterized by temporary functional strain.

“It is applied across domains where additional symptomatic support is needed when symptoms related to irritative states lead to noticeable interference with comfort and function.”

Quick Fact: Symptomatic Relief in Cases of Inflamed Gums and Minor Skin Irritation

Eligibility and Restrictions for Use

The eligibility profile for Chlorhexidine C (Chlorhexidine Gluconate) is defined by strict regulatory parameters concerning patient history, age, and the intended site of application, as documented in official government labeling.

Eligibility Scope

Population Regulatory Status Context/Condition
Known Hypersensitivity Absolute Contraindication Allergy to chlorhexidine gluconate or any formula ingredient.
Children under 18 (Oral Rinse) Use Not Established Safety and effectiveness have not been demonstrated in this age group.
Infants under 2 months (Topical) Restricted/Caution Use requires special care due to regulatory warnings about potential chemical burns.
Pregnant Women Conditional Use Use is permitted only if clearly needed (Pregnancy Category B/C).

The medicine must not be used in contact with the meninges, for lumbar puncture, in the eye, or instilled into the middle ear if the eardrum is perforated. Furthermore, certain topical solutions are prohibited for use on open or broken skin. The oral chip formulation is not recommended for a patient presenting with an acutely abscessed periodontal pocket. Caution is exercised when prescribing to nursing mothers and older adults due to limited data or potential for decreased organ function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Chlorhexidine C (Chlorhexidine Gluconate) is distinguished by the documented absence of systemic drug–drug interactions, which aligns with its use as a topical and local antimicrobial agent having minimal absorption. Government regulatory documents do not cite evidence for interactions based on metabolic enzymes, drug transporters, or subsequent altered systemic exposure of the agent.

Interaction Scope Official Regulatory Statement
Medicinal Products None Documented. Regulatory information does not list any specific prescription or non-prescription medicines as having clinically relevant pharmacokinetic or pharmacodynamic interactions with Chlorhexidine C.
Timing-Based Rules (Oral Rinse) The oral rinse requires time separation from water, other mouthwashes, food, and drink. This constraint is officially documented to prevent the removal or inactivation of the agent, thereby maintaining its local effectiveness.
Substance Incompatibility Chlorine-Releasing Products (e.g., household bleach) pose a chemical incompatibility risk with the topical solution. Contact during laundering is documented to cause a chemical reaction resulting in permanent brown staining of exposed fabrics.

The regulatory framework for Chlorhexidine C establishes its interaction structure based on these local efficacy constraints and specific chemical limitations. The profile provides necessary detail on required administration separation and procedural restrictions rather than traditional medication-specific cautions.

Mechanism of Action

How Chlorhexidine C Works

The mechanism of Chlorhexidine Gluconate (CHG) is a rapid, non-systemic process achieved through strong physicochemical interaction with microbial structures, achieving local microbial disruption.

Cationic Binding and Cell Membrane Destruction

This mechanism is initiated by the positive charge of the CHG molecule, which causes it to be strongly attracted to and bind with the negatively charged components (phosphate groups) found on the surface of microbial cell membranes and cell walls. This electrostatic binding rapidly disrupts the structural integrity of the cell barrier, causing essential internal contents to leak out, which results in the rapid inactivation of pathogens at the site of interaction.

Concentration-Dependent Cytoplasmic Coagulation

The destruction of the cell membrane is followed by a lethal event where CHG penetrates the cell, causing the coagulation and precipitation of internal proteins and nucleic acids in the cytoplasm. This is a concentration-dependent cascade; low concentrations may only inhibit growth (bacteriostasis), but the high concentrations typically used cause immediate, irreversible cell damage (cytolysis), which results in the irreversible cell damage and inactivation of the microorganism.

Substantivity for Prolonged Local Action

The strong cationic binding mechanism that damages microbes also allows the CHG molecule to adhere tightly to the stratum corneum (outer layer of the skin) or mucosa. This adherence creates a local reservoir of the active compound, resulting in substantivity—the persistence of antimicrobial activity after initial application, thereby sustaining the local molecular concentration available for continued microbial inactivation.

Dosage and Administration Information

How to Use Chlorhexidine C

Chlorhexidine C (Chlorhexidine Gluconate) administration is defined by its approved routes: topical for skin and wound cleansing, and oral for use on the mucosal surfaces of the mouth. The usage patterns are governed by standardized protocols concerning volume, contact time, and frequency.

Official Administration Guidelines

Usage Parameter Oral Rinse (0.12%) Topical Solutions (e.g., 4%)
Administration Route Oral (Mucosal) Topical (Skin/Wounds)
Standard Adult Dose 15 mL undiluted solution Approximately 5 mL per wash/scrub cycle
Frequency Twice daily As required for cleansing or procedures
Contact Time Swish for 30 seconds Varies by indication (e.g., 30 seconds for handwash)

Specific Procedural Requirements

When using the oral rinse, the prescribed 15 mL dose must be used undiluted and swished for the full 30 seconds. The solution must be expectorated (spit out) and not swallowed. To avoid deactivation, the rinse is administered after routine dental care, and individuals must refrain from eating, drinking, or rinsing with water for at least 30 minutes after use. Topical solutions for cleansing are also used full strength and require a thorough rinse with water following application.

Duration and Population Rules

Continuous use of the oral rinse formulation typically requires clinical re-evaluation beyond a six-month period. For specific populations, the oral rinse is generally not recommended for routine use in pediatric patients under 18 years of age, and topical preparations should be used with caution or avoided entirely in infants under two months.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Chlorhexidine C

Evidence for Use in Symptomatic Manifestations of Gingivitis

The primary evidence was studied for exploring how symptoms related to temporary or heightened manifestations of gingivitis are measured in research, a condition linked to inflammatory or irritative states in the gums. This evidence is built upon primarily short-term and intermediate-term Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews. These studies monitored changes in clinical measurement tools, such as the Gingival Index and Plaque Index, which serve as measures of inflammation and microbial buildup. Research focused on adults and adolescents who presented with inflammation in the gums.

Clinical trials and meta-analyses reported that the oral rinse formulation registered measurements related to the Gingival Index and Gingival Bleeding Index that differed from control group measurements. Studies reported that measurements of microbial accumulation differed in the observed populations. However, the long-term effects are not fully established because most research reports observation periods of six months or less.

Evidence for Use in Topical Antisepsis and Minor Wound Care

The topical form of Chlorhexidine C was evaluated in research examining localized germ measurements on the skin. The research includes a large number of RCTs that compared the agent against other forms of skin preparation, as well as extensive Systematic Reviews focused on infection prevention. The research examined outcomes related to infection rates and measures of microbial load reduction on the skin surface before and after application. The study populations included a broad range of adults who required skin preparation, as well as general populations with minor skin breaks.

Comparative studies reported that the topical agent registered measurements of microbial load reduction that differed from control groups. Studies also monitored measurements of post-procedure infection rates that differed from control groups. The evidence structure is extensive for research conducted in preparation settings, but the results apply only to the populations studied.

What the Research Landscape Shows Remains Uncertain

One key limitation is that many findings are based on surrogate clinical markers, such as index scores, and do not necessarily capture outcomes reflecting daily functioning or activity level. Furthermore, data for certain groups remain insufficient, particularly for very young children or specific comorbidity-defined groups.

Finally, the long-term effects are not fully established, and continued research is needed to explore the long-term patterns of use beyond the typical follow-up durations of existing trials.

How should Chlorhexidine C be stored and disposed of?

Storage and Disposal of Chlorhexidine Gluconate

Chlorhexidine Gluconate (CHG) products must be stored strictly according to official regulatory labeling to ensure stability and safety.

Storage Requirements

CHG is typically stored at controlled room temperature (20 C to 25 C). It must be protected from light, moisture, freezing, and excessive heat (above 40 C). The medicine must be kept in its original container, tightly closed, and out of the sight and reach of children (utilizing a child-resistant closure for prescription forms).

Disposal

Disposal of unused or expired product must follow local environmental regulations. Non-liquid forms, such as cloths, often carry a specific instruction to not flush them. Always discard single-use products after use.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagRussia

Equivalent of Chlorhexidine C found in:

A-Z Index: